2006;152:661 7. 121. Ting HH, Rihal CS, Gersh BJ, et al. Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol. Circulation. 2007;116:729 36. 122. American Heart Association. Mission Lifeline. Available at: http://www. heart.org/HEARTORG/HealthcareResearch/MissionLifelineHomePage/ cessed July 26, 2012. 123. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplas- ty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J. 2009;30:1598 606. 124. Bradley EH, Curry LA, Ramanadhan S, et al. Research in action: us- ing positive deviance to improve quality of health care. Implement Sci. 2009;4:25. 125. Widimsk P, Budes nsk T, Vor c D, et al. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction: final results of the randomized national multicentre trial: PRAGUE-2. Eur Heart J. 2003;24:94 104. 126. Chakrabarti A, Krumholz HM, Wang Y, et al. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2008;51:2442 3. 127. Wang TY, Peterson ED, Ou F-S, et al. Door-to-balloon times for patients with ST-segment elevation myocardial infarction requiring interhospital transfer for primary percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. Am Heart J. 2011;161:76 83.e1. 128. Miedema MD, Newell MC, Duval S, et al. Causes of delay and associ- ated mortality in patients transferred with ST-segment-elevation myocar- dial infarction. Circulation. 2011;124:1636 44. 129. Wang TY, Nallamothu BK, Krumholz HM, et al. Association of door-in to door-out time with reperfusion delays and outcomes among patients transferred for primary percutaneous coronary intervention. JAMA. 2011;305:2540 7. 130. Primary versus tenecteplase-facilitated percutaneous coronary interven- tion in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. 